These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31944219)
1. Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy. Agarwal A; Dayal A; Kircher SM; Chen RC; Royce TJ JAMA Oncol; 2020 Mar; 6(3):409-412. PubMed ID: 31944219 [TBL] [Abstract][Full Text] [Related]
2. Price transparency implementation: Accessibility of hospital chargemasters and variation in hospital pricing after CMS mandate. Lu AJ; Chen EM; Vutam E; Brandt J; Sadda P Healthc (Amst); 2020 Sep; 8(3):100443. PubMed ID: 32919582 [TBL] [Abstract][Full Text] [Related]
3. Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule. Gul ZG; Sharbaugh DR; Guercio CJ; Pelzman DL; Jones CA; Hacker EC; Anyaeche VI; Bowers L; Shah AM; Stencel MG; Yabes JG; Jacobs BL; Davies BJ JAMA Netw Open; 2023 Jan; 6(1):e2249581. PubMed ID: 36602800 [TBL] [Abstract][Full Text] [Related]
4. Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate. Brant A; Lewicki P; Rhodes S; Arenas-Gallo C; Strasser MO; Zhu A; Ponsky L; Shoag JE Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):252-256. PubMed ID: 36717642 [TBL] [Abstract][Full Text] [Related]
5. Health Care Price Transparency in Ophthalmology. Berkowitz ST; Siktberg J; Hamdan SA; Triana AJ; Patel SN JAMA Ophthalmol; 2021 Nov; 139(11):1210-1216. PubMed ID: 34617970 [TBL] [Abstract][Full Text] [Related]
6. Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures. Burkhart RJ; Hecht CJ; Acuña AJ; Kamath AF Clin Orthop Relat Res; 2022 Dec; 480(12):2316-2326. PubMed ID: 35901439 [TBL] [Abstract][Full Text] [Related]
8. Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers. Kasthuri VS; Alsoof D; Balmaceno-Criss M; Daher M; McDonald CL; Diebo BG; Kuris EO; Daniels AH Spine J; 2024 Feb; 24(2):304-309. PubMed ID: 38440969 [TBL] [Abstract][Full Text] [Related]
9. Survey of Hospital Chargemaster Transparency. Arvisais-Anhalt S; McDonald S; Park JY; Kapinos K; Lehmann CU; Basit M Appl Clin Inform; 2021 Mar; 12(2):391-398. PubMed ID: 33951742 [TBL] [Abstract][Full Text] [Related]
11. The Price-Quality Mismatch: Are Negotiated Prices for Total Joint Arthroplasty Associated With Hospital Quality in a Large California Health System? Zhuang T; Shapiro LM; Baker LC; Kamal RN Clin Orthop Relat Res; 2023 Jun; 481(6):1061-1068. PubMed ID: 36729581 [TBL] [Abstract][Full Text] [Related]
12. Investigation of Hospital Pricing Information for Plastic Surgery Procedures Reveals Widespread Violation of the CMS Price Transparency Act. Askinas C; Shih S; Puyana S; Chaffin AE; Jansen DA Plast Reconstr Surg; 2023 Aug; 152(2):455-462. PubMed ID: 36790781 [TBL] [Abstract][Full Text] [Related]
13. Not Clearing the Air: Hospital Price Transparency for a Laparoscopic Cholecystectomy. Green RL; Dunham P; Kling SM; Kuo LE J Surg Res; 2022 Dec; 280():501-509. PubMed ID: 36081309 [TBL] [Abstract][Full Text] [Related]
14. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers. Sankaran R; O'Connor J; Nuliyalu U; Diaz A; Nathan H Ann Surg Oncol; 2024 Jul; 31(7):4339-4348. PubMed ID: 38506934 [TBL] [Abstract][Full Text] [Related]
15. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance. Xiao R; Ross JS; Gross CP; Dusetzina SB; McWilliams JM; Sethi RKV; Rathi VK JAMA Intern Med; 2022 Jun; 182(6):603-611. PubMed ID: 35435948 [TBL] [Abstract][Full Text] [Related]
16. Evaluating hospital consumer-friendly price-estimator tools for shoppable services within dermatology. Yang K; Drake L; Ghatnekar S; Kassamali B; Nambudiri VE Arch Dermatol Res; 2023 Aug; 315(6):1813-1821. PubMed ID: 36705758 [TBL] [Abstract][Full Text] [Related]
17. Increasing Divergence in Drug Prices Between the United States and Germany After Implementation of Comparative Effectiveness Analysis and Collective Price Negotiations. Berkemeier F; Whaley C; Robinson JC J Manag Care Spec Pharm; 2019 Dec; 25(12):1310-1317. PubMed ID: 31778624 [TBL] [Abstract][Full Text] [Related]
18. Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule. Kong E; Ji Y JAMA Netw Open; 2023 Jun; 6(6):e2320694. PubMed ID: 37378982 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion. Issa TZ; Lee Y; Mazmudar AS; Padovano R; Lambrechts MJ; Canseco JA; Hilibrand AS; Vaccaro AR; Kepler CK; Schroeder GD J Am Acad Orthop Surg; 2023 Jul; 31(13):677-686. PubMed ID: 37015104 [TBL] [Abstract][Full Text] [Related]
20. A Radiology-focused Analysis of Transparency and Usability of Top U.S. Hospitals' Chargemasters. Glover M; Whorms D; Singh R; Almeida RR; Prabhakar AM; Saini S; Rosenkrantz AB Acad Radiol; 2020 Nov; 27(11):1603-1607. PubMed ID: 32014405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]